Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.95 (market cap $4.02B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.43 (market cap $4.03B). The key difference: Edgewise Therapeutics Inc. Common Stock and Indivior Pharmaceuticals Inc. Common Stock are close in size by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Indivior Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| EWTX | INDV | |
|---|---|---|
Market Cap | $4.02B | $4.03B |
Volume | 1,446,128 | 2,781,171 |
Sector | Health | Health |
52-Week High | $48.35 | $41.83 |
52-Week Low | $14.89 | $24.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.56B | $4.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →
